Use of dehydroepiandrosterone to treat primary adrenal insufficiency and Addison's disease
US5861391A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Jan 29, 1997 |
| Grant date | Jan 19, 1999 |
| Priority date | — |
| Expiry date | Jan 29, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/5685
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method of treating an individual with primary adrenal insufficiency, comprising the step of administering an effective amount of dehydroepiandrosterone to said individual. Also provided is a method of treating an individual with adrenal failure secondary to dysfunctions of the hypothalamus and/or pituitary gland, comprising the step of administering an effective amount of dehydroepiandrosterone to said individual and a method of treating an individual with adrenal insufficiency due to acquired human immunodeficiency syndrome (AIDS), comprising the step of administering an effective amount of deyhydroepiandrosterone to said individual.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.